Dominik Steubl

Company: Boehringer Ingelheim

Job title: Senior Clinical Program Leader

Seminars:

Panel Discussion: Pursuing the Next Gold Standard in Biomarker Development: Interrogating the Roadmap from Experimental to Validated 12:00 pm

• Developing molecular multi-marker panels to investigate how novel therapeutics interfere with disease processes and validating with longitudinal data • Proteomics, urinary transcriptomics, PROs and microRNA analysis: what correlates with clinical outcome and what is needed for validation? • How aggressively can we pursue surrogate endpoints?Read more

day: Track 2 - Day 1 AM